This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
by Zacks Equity Research
IART's first-quarter 2025 earnings lag the consensus mark. Q2 revenue projections are bleak.
Compared to Estimates, Integra (IART) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Integra LifeSciences (IART) Q1 Earnings Miss Estimates
by Zacks Equity Research
Integra (IART) delivered earnings and revenue surprises of -4.65% and 0.13%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Integra (IART) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Integra (IART) stock based on the movements in the options market lately.
Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is This the Right Time to Hold Integra Stock in Your Portfolio?
by Zacks Equity Research
IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
by Zacks Equity Research
IART delivers better-than-expected earnings in the fourth quarter of 2024.
Integra (IART) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Integra LifeSciences (IART) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Integra (IART) delivered earnings and revenue surprises of 14.12% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
IART vs. SONVY: Which Stock Is the Better Value Option?
by Zacks Equity Research
IART vs. SONVY: Which Stock Is the Better Value Option?